Preclinical Safety of DNA Vaccines: A Method to Analyze the Distribution of Plasmid DNA in Animal Models
- 31 December 1999
- book chapter
- Published by Springer Nature
- Vol. 29, 473-488
- https://doi.org/10.1385/1-59259-688-6:473
Abstract
DNA or genetic vaccines are currently being evaluated for safety and efficacy in human clinical trials in the areas of infectious disease and cancer. Since DNA vaccines induce antibodies and cytotoxic T lymphocytes (CTLs), they are currently being evaluated in humans for both prevention and therapy of HSV-2, HIV-1, and HBV infections, for prevention of influenza and malaria, and therapy of cutaneous T-cell lymphoma (CTCL) and colorectal cancer.Keywords
This publication has 0 references indexed in Scilit: